title: Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required.
authors.forename: K
authors.initials: K
authors.lastname: Hu
authors.forename: S E
authors.initials: SE
authors.lastname: Horgan
authors.forename: R R
authors.initials: RR
authors.lastname: Sivaraj
authors.forename: K
authors.initials: K
authors.lastname: Avgikos
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012170:Retinal Vein Occlusion / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab